Who
David Pendarvis
Director
Company insider
Files Form 4 as: Director, Wd-40; Chief Administrative Officer, ResMed; Director, Sequenom.
In numbers
- Trades disclosed
- 500
- Buys
- 3
- Sells
- 131
- Bought
- $389K
- Sold
- $66.3M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 3 Feb 2006
- Last trade
- 5 Feb 2026
- Last filed
- 6 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Feb 2026filed 6 Feb 2026 | WDFC Wd-40Chemicals | SEC FORM 4 Bought | $105K424 at $247.15 | filing |
| 5 Feb 2026filed 6 Feb 2026 | WDFC Wd-40Chemicals | SEC FORM 4 Bought | $105K424 at $247.15 | filing |
| 12 Dec 2025filed 12 Dec 2025 | WDFC Wd-40Chemicals | SEC FORM 4 Code A | —612 | filing |
| 30 Oct 2025filed 30 Oct 2025 | WDFC Wd-40Chemicals | SEC FORM 4 Bought | $103K523 at $196.37 | filing |
| 12 Dec 2024filed 16 Dec 2024 | WDFC Wd-40Chemicals | SEC FORM 4 Code A | —412 | filing |
| 12 Apr 2024filed 12 Apr 2024 | WDFC Wd-40Chemicals | SEC FORM 4 Bought | $77K328 at $234.75 | filing |
| 12 Dec 2023filed 13 Dec 2023 | WDFC Wd-40Chemicals | SEC FORM 4 Code A | —406 | filing |
| 5 Jun 2023filed 7 Jun 2023 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $330K1,500 at $219.79 | filing |
| 3 May 2023filed 4 May 2023 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $356K1,500 at $237.64 | filing |
| 3 Apr 2023filed 5 Apr 2023 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $327K1,500 at $218.23 | filing |
| 3 Mar 2023filed 7 Mar 2023 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $325K1,500 at $216.69 | filing |
| 3 Feb 2023filed 6 Feb 2023 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $337K1,500 at $224.50 | filing |
| 3 Jan 2023filed 5 Jan 2023 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $315K1,500 at $210.07 | filing |
| 13 Dec 2022filed 15 Dec 2022 | WDFC Wd-40Chemicals | SEC FORM 4 Code A | —840 | filing |
| 5 Dec 2022filed 6 Dec 2022 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $345K1,500 at $229.81 | filing |
| 28 Nov 2022filed 29 Nov 2022 | RMD ResMedMedical Devices | SEC FORM 4 Code G | —7,300 at $0.00 | filing |
| 25 Nov 2022filed 29 Nov 2022 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —683 at $0.00 | filing |
| 25 Nov 2022filed 29 Nov 2022 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $100K683 at $146.34 | filing |
| 23 Nov 2022filed 23 Nov 2022 | RMD ResMedMedical Devices | SEC FORM 4 Code A | —12,389 at $0.00 | filing |
| 23 Nov 2022filed 23 Nov 2022 | RMD ResMedMedical Devices | SEC FORM 4 Code F | $1.6M6,911 at $224.40 | filing |
News
WD-40 targets 4% to 7% FY 2027 net sales growth and $6.40 to $6.70 EPS as gross margin rebounds from Q4 low (NASDAQ:WDFC)WDFC · seekingalpha.com · 22 Oct 2026This WD-40 Hack For Halloween Has The Oil Flying Off The ShelvesWDFC · kcrr.com · 21 Oct 2026WD-40 Leads $40 Million in Dividends With October 19 Ex-DateWDFC · 247wallst.com · 19 Oct 2026
0 headlines in the last 90 days name David Pendarvis; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.